David R W Jayne

60PUBLICATIONS
226CO-AUTHORS
AutoimmunityPharmacogenomicsOther European languagesEpidemiological modellingHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|May 23, 2026
Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.

|Mar 24, 2026
Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study.

David R W Jayne, Raashid Luqmani, Benjamin Terrier

|Mar 19, 2026
Reply.

Aglaia Chalkia, David Jayne

|Feb 09, 2026
Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort.

Matthias Papo, Pauline Martinot, Renato A Sinico

|Feb 09, 2026
Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A European Multicenter Study.

Aglaia Chalkia, Marusa Kotnik, Timothy J Sadler

|Dec 18, 2025
Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab.

Ellen Romich, Joshua F Baker, Thomas R Riley Iv

Pageof 10

Frequent Collaborators

13 joint publications

Peter Merkel

9 joint publications

Aladdin J Mohammad

7 joint publications

Andreas Kronbichler

7 joint publications

Ulrich Specks